FORT LEE, N.J.--(BUSINESS WIRE)--Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today that John Mordock, the company’s Chief Executive Officer, will present at the 4th annual Neurotech Industry Investing and Partnering Conference 2009, to be held May 11-13 at The St. Regis hotel in San Francisco, CA.
